
© 2024 Moneycab
Realtime | Geld | Brief | Zeit |
---|---|---|---|
74,40 | 74,54 | 08.05. | |
74,37 | 74,59 | 08.05. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Cosmo Pharmaceuticals N.V.: Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Week(R) 2025 | Dublin, Ireland--(Newsfile Corp. - May 5, 2025) - Cosmo is attending this year's Digestive Disease Week® (DDW), held in San Diego, California from May 3-6, where its leadership team is advancing... ► Artikel lesen | |
02.05. | Cosmo Pharmaceuticals N.V.: Cosmo Announces EU MDR Certification for Endovision's Cerebro, expanding its real-time AI ecosystem | Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision Limited, a leading innovator in endoscopic imaging solutions, has received EU MDR certification[1]... ► Artikel lesen | |
30.04. | XETR DELETION OF INSTRUMENTS FROM XETRA - 30.04.2025 | The following instruments on XETRA do have their last trading day on 30.04.2025.Die folgenden Instrumenteauf XETRA haben ihren letzten Handelstag am 30.04.2025.ISIN NameNL0011832936 Cosmo Pharmaceuticals... ► Artikel lesen | |
29.04. | Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Confirms Financial Guidance Following CHMP Opinion on Winlevi(R) | Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Following the recent CHMP opinion regarding the marketing authorization application for Winlevi® (clascoterone cream 1%) in Europe, Cosmo Pharmaceuticals... ► Artikel lesen | |
29.04. | Cosmo erhält negative Empfehlung von EU-Ausschuss für Aknemittel |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch | ||
Do | Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 | ||
Mi | What Are Wall Street Analysts' Target Price for Medtronic Stock? | ||
Di | Medtronic: Reading Your Brain Waves To Treat a Debilitating Disease | FDA approves Medtronic adaptive deep brain stimulation system for Parkinson's Disease NORTHAMPTON, MA / ACCESS Newswire / May 6, 2025 / Liza Bobrow didn't think it was a big deal when her handwriting... ► Artikel lesen | |
Mo | Ex-Moderna brand chief Kate Cronin joins Medtronic Diabetes as marketing head |
Unternehmen / Aktien | Kurs | % |
---|---|---|
COSMO PHARMACEUTICALS NV | 53,50 | -0,93 % |
MEDTRONIC PLC | 74,48 | 0,00 % |